Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

First-in-human Pilot Study for the Safety Assessment of DXM Gel in Patients With Painful Lumbar Degenerative Disc Disease

NCT04727385 is registered in ClinicalTrials.gov with Gelmetix as lead sponsor.

NCT NCT04727385
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04727385 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
First-in-human Pilot Study for the Safety Assessment of DXM Gel in Patients With Painful Lumbar Degenerative Disc Disease
Lead sponsor
Gelmetix
Phase
Not applicable
Overall status
Unknown status
Start date
September 15, 2020
Completion date
October 31, 2021
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic lower back pain, degenerative disc disease, discogenic pain, intervertebral disc degeneration, lumbar disc degeneration, lumbar disc disease, lumbar disc pain